secwatch / observer
8-K filed November 12, 2024, 6:59 PM ET ticker IRWD CIK 0001446847
leadership confidence high sentiment neutral materiality 0.40

Ironwood CBO Andrew Davis resigns effective Nov 22, 2024

IRONWOOD PHARMACEUTICALS INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew Davis

Senior Vice President, Chief Business Officer
IRWD · IRONWOOD PHARMACEUTICALS INC
Effective
2024-11-22
Filed
November 12, 2024, 6:59 PM ET
Andrew Davis notified Ironwood Pharmaceuticals, Inc. (the “Company”) that he is resigning from his position as Senior Vice President, Chief Business Officer, effective November 22, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Davis departed as Senior Vice President, Chief Business Officer at IRONWOOD PHARMACEUTICALS INC.

Action
resigning
Role
Senior Vice President, Chief Business Officer
Exact text from the filing
Andrew Davis notified Ironwood Pharmaceuticals, Inc. (the “Company”) that he is resigning from his position as Senior Vice President, Chief Business Officer, effective November 22, 2024.
View on SEC.gov

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001104659-24-116764
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.